Lv1
20 积分 2025-08-04 加入
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
7个月前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
8个月前
已完结
厄洛替尼治疗肺腺癌眼内转移一例
8个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
9个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
9个月前
已关闭
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
1年前
已完结
皖公网安备34019202002308
